You are here

Prices & Quotes - UK Markets - AstraZeneca (AZN)

Risk Warning The value of investments can fall as well as rise and any income from them is not guaranteed and you may get back less than you invested. Past performance is not a guide to future performance.

Share Price:
Down 7,632.00p
Change Today:
-85.00p
Market Cap:
£100,189m
Sector:
Pharmaceuticals & Biotechnology

Denmark scraps use of AstraZeneca vaccine

By Sean Farrell

Date: Wednesday 14 Apr 2021

LONDON (ShareCast) - (Sharecast News) - Denmark has stopped using AstraZeneca's vaccine in its Covid-19 inoculation programme because of concerns about cases of rare blood clots.

The Danish health authority said the possible link between the vaccine and blood clots and the virus being under control in Denmark led it to be the first EU country to scrap the jab indefinitely.

Denmark paused use of the AstraZeneca vaccine on 11 March. Since then the European Medicines Authority has said there was a link between the jab and blood clots but said the risk was small compared to that of Covid-19. Denmark has also found higher than expected incidents of clots in people who received the AstraZeneca shot, the Danish authority said.

Based on the scientific findings, our overall assessment is there is a real risk of severe side effects associated with using the Covid-19 vaccine from AstraZeneca," General Søren Brostrøm, the authority's director general, said. "We have, therefore, decided to remove the vaccine from our vaccination programme.

"In the midst of an epidemic, it has been a difficult decision to continue our vaccination programme without an effective and readily available vaccine against Covid-19. However, we have other vaccines at our disposal, and the epidemic is currently under control."

All appointments for the AstraZeneca vaccine will be cancelled and people who have had one of the jabs will be invited to have an alternative, the authority said. If the situation changes, Denmark could allow the AstraZeneca vaccine back into its programme.

Several European countries suspended AstraZeneca's vaccine in March along with Denmark but most have restarted using it though often only for older age groups. On Tuesday the US, Canada and the EU paused use of Johnson & Johnson's vaccine, which is similar to AstraZeneca's, because of clotting concerns.

AstraZeneca shares rose 1.7% to £72.86 at 15:21 BST.



Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

AstraZeneca Market Data

Currency UK Pounds
Price 7,632.00p
Change Today -85.00p
52 Week High 9,320.00p
52 Week Low 6,794.00p
Volume 1,885,271
Shares Issued 1,312.75m
Market Cap £100,189m
Beta 0.01

Performance Indicators

Compare performance with the sector and the market.

Key
Vs Market
Vs Sector
Value
market
  1. half market star
  2. empty market
  3. empty market
  4. empty market
  5. empty market
sector
  1. full sector star
  2. full sector star
  3. full sector star
  4. full sector star
  5. empty sector
Price Trend
market
  1. full market star
  2. empty market
  3. empty market
  4. empty market
  5. empty market
sector
  1. full sector star
  2. empty sector
  3. empty sector
  4. empty sector
  5. empty sector
Income
market
  1. full market star
  2. full market star
  3. empty market
  4. empty market
  5. empty market
sector
  1. full sector star
  2. full sector star
  3. full sector star
  4. half sector star
  5. empty sector
Growth
market
  1. full market star
  2. full market star
  3. full market star
  4. full market star
  5. half market star
sector
  1. full sector star
  2. full sector star
  3. full sector star
  4. full sector star
  5. half sector star
Price Chg 6m
market
  1. empty market
  2. empty market
  3. empty market
  4. empty market
  5. empty market
sector
  1. full sector star
  2. empty sector
  3. empty sector
  4. empty sector
  5. empty sector
P/E
market
  1. full market star
  2. empty market
  3. empty market
  4. empty market
  5. empty market
sector
  1. full sector star
  2. full sector star
  3. empty sector
  4. empty sector
  5. empty sector
PEG
market
  1. half market star
  2. empty market
  3. empty market
  4. empty market
  5. empty market
sector
  1. half sector star
  2. empty sector
  3. empty sector
  4. empty sector
  5. empty sector
Dividend Yield
market
  1. full market star
  2. full market star
  3. half market star
  4. empty market
  5. empty market
sector
  1. full sector star
  2. full sector star
  3. full sector star
  4. full sector star
  5. empty sector
EPS Growth
market
  1. full market star
  2. full market star
  3. full market star
  4. full market star
  5. half market star
sector
  1. full sector star
  2. full sector star
  3. full sector star
  4. full sector star
  5. full sector star
Operating Margin
market
  1. full market star
  2. full market star
  3. full market star
  4. half market star
  5. empty market
sector
  1. full sector star
  2. full sector star
  3. full sector star
  4. full sector star
  5. empty sector

What The Brokers Say

Strong Buy 22
Buy 2
Neutral 2
Sell 0
Strong Sell 1
Total 27
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

AstraZeneca Dividends

  Latest Previous
  2nd Interim 1st Interim
Ex-Div 25-Feb-21 13-Aug-20
Paid 29-Mar-21 14-Sep-20
Amount 190.00¢ 90.00¢

Trades for 11-May-2021

Time Volume / Share Price
16:45 24 @ 7,624.00p
16:45 24 @ 7,624.00p
16:37 63,000 @ 7,610.58p
16:35 1,000 @ 7,632.00p
16:35 1,000 @ 7,632.00p

AstraZeneca Key Personnel